Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Anticalins: a Novel Class of Therapeutic Binding Proteins

Anticalins - engineered human lipocalin proteins - provide a novel class of biopharmaceutical drug candidates with simialr binding and recognition properties as antibodies, while offering several fundamental advantages.

Andreas M. Hohlbaum and Arne Skerra of Pieris AG (November 2007)

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |